Literature DB >> 20824371

National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis.

Skye C Mayo1, Andrew D Shore, Hari Nathan, Barish Edil, Christopher L Wolfgang, Kenzo Hirose, Joseph Herman, Richard D Schulick, Michael A Choti, Timothy M Pawlik.   

Abstract

INTRODUCTION: National Comprehensive Cancer Network (NCCN) guidelines recommend hepatic resection and lymphadenectomy (LND) for gallbladder adenocarcinoma (GBA). We sought to evaluate compliance with these recommendations and to assess trends in the management and survival of patients with GBA.
METHODS: Using Surveillance, Epidemiology and End Results (SEER)-Medicare-linked data, we identified 2,955 patients with GBA who underwent cancer-directed surgery from 1991 to 2005. We assessed clinicopathologic data, trends in surgical management, and survival.
RESULTS: From 1991 to 2005, preoperative evaluation included CT (62%), MRI (6%), and PET (2%). Only 383 (13%) patients underwent radical resection/hepatectomy with a temporal increase over the study period (1991-1995, 12%; 1996-1999, 10%; 2000-2002, 12.0%; 2003-2005, 16%; P < 0.001). For patients undergoing radical resection/hepatectomy, LND ≥ 3 nodes was performed in 96 (3%) patients. Among patients who had LND, 47% had nodal metastasis. The overall 1-, 3-, and 5-year survival was 56%, 30%, and 21%. On multivariate analysis, radical resection/hepatectomy (hazard ratio (HR) = 0.71) and LND ≥ 3 nodes (HR = 0.56) were independently associated with increased survival. There was no significant improvement in survival over time (P = 0.60).
CONCLUSIONS: Compliance with NCCN guidelines for GBA remains poor. Survival of patients with surgically managed GBA has not improved over time.

Entities:  

Mesh:

Year:  2010        PMID: 20824371     DOI: 10.1007/s11605-010-1335-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  40 in total

1.  A study of prognostic factors for hepatic resection for colorectal metastases.

Authors:  M Taylor; J Forster; B Langer; B R Taylor; P D Greig; C Mahut
Journal:  Am J Surg       Date:  1997-06       Impact factor: 2.565

2.  Limitations of claims and registry data in surgical oncology research.

Authors:  Hari Nathan; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2007-11-07       Impact factor: 5.344

Review 3.  Evolving treatment strategies for gallbladder cancer.

Authors:  Matthew T Hueman; Charles M Vollmer; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2009-06-03       Impact factor: 5.344

4.  Biology dictates prognosis following resection of gallbladder carcinoma: sometimes less is more.

Authors:  Timothy M Pawlik; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2009-01-23       Impact factor: 5.344

5.  Reoperation as a quality indicator in colorectal surgery: a population-based analysis.

Authors:  Arden M Morris; Laura-Mae Baldwin; Barbara Matthews; Jason A Dominitz; William E Barlow; Sharon A Dobie; Kevin G Billingsley
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

6.  Radical resection improves survival for patients with pT2 gallbladder carcinoma.

Authors:  P E Wise; Y Y Shi; M K Washington; W C Chapman; J K Wright; K W Sharp; C W Pinson
Journal:  Am Surg       Date:  2001-11       Impact factor: 0.688

7.  Predictors of long-term survival in patients with gallbladder cancer.

Authors:  Palat Balachandran; Shaleen Agarwal; Narendra Krishnani; Chandra M Pandey; Ashok Kumar; Sadiq S Sikora; Rajan Saxena; Vinay K Kapoor
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

8.  A critical analysis of the surgical management of early-stage gallbladder cancer in the United States.

Authors:  Eric H Jensen; Anasooya Abraham; Elizabeth B Habermann; Waddah B Al-Refaie; Selwyn M Vickers; Beth A Virnig; Todd M Tuttle
Journal:  J Gastrointest Surg       Date:  2008-12-13       Impact factor: 3.452

9.  Surgery for gallbladder cancer: a population-based analysis.

Authors:  Natalie G Coburn; Sean P Cleary; Jensen C C Tan; Calvin H L Law
Journal:  J Am Coll Surg       Date:  2008-05-12       Impact factor: 6.113

Review 10.  Operative mortality after hepatic resection: are literature-based rates broadly applicable?

Authors:  Bolanle Asiyanbola; David Chang; Ana Luiza Gleisner; Hari Nathan; Michael A Choti; Richard D Schulick; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2008-02-12       Impact factor: 3.452

View more
  48 in total

1.  Bile duct surgery in the treatment of hepatobiliary and gallbladder malignancies: effects of hepatic and vascular resection on outcomes.

Authors:  Perry Shen; Nora Fino; Edward A Levine; Pamela Eversole; Clancy Clark
Journal:  HPB (Oxford)       Date:  2015-09-16       Impact factor: 3.647

2.  Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer.

Authors:  Dong Hyun Kim; Sung Hoon Kim; Gi Hong Choi; Chang Moo Kang; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

Review 3.  Key factors influencing prognosis in relation to gallbladder cancer.

Authors:  Charles Henry Caldow Pilgrim; Ryan T Groeschl; Kiran K Turaga; T Clark Gamblin
Journal:  Dig Dis Sci       Date:  2013-05-22       Impact factor: 3.199

4.  Prognostic Impact of Lymph Node Excision in T1 and T2 Gallbladder Cancer: a Population-Based and Propensity Score-Matched SEER Analysis.

Authors:  Thomas Steffen; Sabrina M Ebinger; Ignazio Tarantino; Bernhard Widmann
Journal:  J Gastrointest Surg       Date:  2019-03-18       Impact factor: 3.452

Review 5.  Immunotherapeutic Approaches to Biliary Cancer.

Authors:  Urvi A Shah; Amara G Nandikolla; Lakshmi Rajdev
Journal:  Curr Treat Options Oncol       Date:  2017-07

6.  Does the Frequency of Cholecystectomy Affect the Ensuing Incidence of Gallbladder Cancer in Sweden? A Population-Based Study with a 16-Year Coverage.

Authors:  R Noel; U Arnelo; L Lundell; G Sandblom
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

7.  Adjuvant Therapy for Gallbladder Cancer: an Analysis of the National Cancer Data Base.

Authors:  Richard S Hoehn; Koffi Wima; Audrey E Ertel; Alexandra Meier; Syed A Ahmad; Shimul A Shah; Daniel E Abbott
Journal:  J Gastrointest Surg       Date:  2015-08-21       Impact factor: 3.452

8.  A Novel Prediction Model for Bloodstream Infections in Hepatobiliary-Pancreatic Surgery Patients.

Authors:  Po-Sheng Yang; Chang-Pan Liu; Yi-Chiung Hsu; Chuen-Fei Chen; Chi-Chan Lee; Shih-Ping Cheng
Journal:  World J Surg       Date:  2019-05       Impact factor: 3.352

9.  Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium.

Authors:  Georgios Antonios Margonis; Faiz Gani; Stefan Buettner; Neda Amini; Kazunari Sasaki; Nikolaos Andreatos; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2016-08-13       Impact factor: 3.647

10.  Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging/scoring systems.

Authors:  Neda Amini; Gaya Spolverato; Yuhree Kim; Rohan Gupta; Georgios Antonios Margonis; Aslam Ejaz; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2014-10-13       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.